Understanding how pre- and post-natal exposures influence brain development using MEG
Register to watch this free webinar on-demand. A link to watch the recording will then be emailed to you shortly after registration.
This MEGIN Masterclass presented by Dr. Julia Stephen will discuss how, “the brain develops rapidly throughout gestation and childhood. However, little is known about how pre- and post-natal exposures impact brain development in children. Our work has focused on examining how rearing environment and prenatal exposures impact brain development using MEG. MEG is especially well-suited for studying children across the age range because it is silent and requires minimal participant preparation time. Rearing environment, including socioeconomic status and maternal factors, influences brain development as revealed by delayed evoked responses and altered neural oscillations. These results indicate rearing environment needs to be accounted for in future studies to better understand human brain development in health and disease.”
Dr. Julia Stephen is a Professor of Translational Neuroscience and the MEG Core Director at The Mind Research Network. She has worked in the field of MEG for over 20 years focusing on understanding the visual system and multisensory integration as well as examining altered brain function in disorders across the lifespan including individuals with Alzheimer’s Disease and Stroke. Recently Dr. Stephen has focused her efforts in understanding brain development in children from infancy to adulthood. MEG is an ideal neuroimaging technique for children providing high resolution signal in a quiet environment. Dr. Stephen's goal is to understand the neurophysiological basis of brain function in typically developing children and children with developmental disorders to optimize outcomes for all children. She has over 120 publications and is funded by the NIH and NSF in pursuit of this goal.
A joining link to watch the MEGIN Masterclass will then be emailed to you shortly after registration.
*MEGIN does not endorse any applications or treatments mentioned at this event. TRIUX™ neo is intended to non-invasively locate regions of epileptic activity within the brain and, in conjunction with other diagnostic data, in neurosurgical planning. All other applications are research in nature.
*By submitting your information to register for a Masterclass, MEGIN will use it to communicate with you regarding this event and other services.